Business Context and Reporting Period
Company: Transcat, Inc. (formerly Transmation, Inc.)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2002 (Second Quarter of Fiscal Year 2003)
Business Overview: Transcat distributes, sells, and services instrumentation used to calibrate, measure, and test physical parameters in industry and science. The company operates two segments: Product Sales and Service Sales. The reporting period reflects significant structural changes, including the divestiture of the Transmation Products Group (TPG) and the Measurement and Control (MAC) unit, and the adoption of SFAS No. 142 regarding goodwill.
Key Financial Metrics
| Metric (in thousands) | Q2 2002 | Q2 2001 | 6 Months 2002 | 6 Months 2001 |
|---|---|---|---|---|
| Net Sales | $14,445 | $16,327 | $28,688 | $33,468 |
| Gross Profit | $3,309 | $4,619 | $6,471 | $9,624 |
| Gross Margin | 22.9% | 28.3% | 22.6% | 28.8% |
| Operating Income | $401 | $12 | $408 | $46 |
| Net Income (Loss) | $509 | $(221) | $(6,108) | $(660) |
| Diluted EPS | $0.08 | $(0.04) | $(1.00) | $(0.11) |
| Cash from Operations (6mo) | $1,048 | |||
| Total Debt (Sept 30, 2002) | $8,784 | |||
| Cash & Equivalents | $229 |
Note: The six-month net loss of $(6,108) includes a non-cash cumulative effect of a change in accounting principle (SFAS No. 142) of $(6,472). Excluding this item, the company reported net income of $364 for the six months.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 11.5% in Q2 and 14.3% for the six months compared to the prior year. This decline is primarily attributed to the divestiture of TPG and MAC units. On an adjusted basis excluding divestitures, product sales were flat in Q2 and down 4.1% for the six months.
- Margin Compression: Gross profit margins declined significantly (from 28.3% to 22.9% in Q2) due to the loss of higher-margin manufacturing sales from the divested TPG unit and a less favorable product mix in the remaining portfolio.
- Expense Reduction: Operating expenses decreased 36.9% in Q2 and 36.7% for the six months. This reduction is driven by the elimination of R&D costs (post-TPG sale), the cessation of goodwill amortization (due to SFAS No. 142), and a workforce reduction program initiated in March 2002.
- Goodwill Impairment: The adoption of SFAS No. 142 resulted in a one-time impairment charge of $6.5 million (71.9% of recorded goodwill) recognized in the first quarter of the fiscal year, impacting the six-month net loss significantly.
Outlook, Risks, and Unusual Items
- Debt Refinancing (Subsequent Event): On November 13, 2002, Transcat refinanced its senior debt with GMAC Business Credit, LLC. The new agreement includes a $1.5 million term loan and a $10 million revolving line of credit. Crucially, the company negotiated a $2.2 million reduction in outstanding debt in exchange for issuing warrants to purchase 500,000 shares of common stock. This transaction is expected to generate a one-time gain of approximately $1.7 million in the third quarter.
- Restructuring: A workforce reduction of 22 employees was completed in March 2002, with an expected annualized cost savings of $1.3 million in fiscal 2003.
- Liquidity: Operating cash flow of $1.0 million for the six months ended September 30, 2002, was used to reduce debt by $1.1 million. Management believes current cash flows and the new credit facility are sufficient to fund operations.
- Risks: The company faces interest rate risk on its variable-rate debt and foreign currency risk (approx. 8-9% of sales in Canadian Dollars). There are no hedging arrangements in place for interest rates.
- Unusual Items: The financial results are heavily influenced by the divestitures, the goodwill impairment charge, and the elimination of R&D and goodwill amortization expenses, making year-over-year comparisons difficult without pro forma adjustments.
Investor Verification Checklist
- Debt Covenant Compliance: Verify the company's ability to meet the new EBITDA covenants under the GMAC Credit Agreement, particularly given the recent goodwill impairment and margin compression.
- Pro Forma Adjustments: Review the "Ongoing Operations" reconciliation table to understand the core business performance excluding the impact of divestitures and one-time charges.
- Warrant Valuation: Assess the dilution impact of the 500,000 warrants issued to previous lenders as part of the debt reduction agreement.
- Inventory Levels: Monitor inventory levels and the new distribution agreement with Fluke, which requires purchasing a larger, pre-determined amount of inventory.
- Calibration Growth: Evaluate the growth trajectory of the two new calibration laboratories opened in fiscal 2002, as management noted growth is slower than anticipated.